Company intelligence / Profile preview

Shanghai United Cell Biotechnology Co., Ltd.

Shanghai, Shanghai, Chinaunitedbiotech.com.cn ↗

Ownership: Private
Employees: ~750
Development stage: Commercial

Overview

SUCB has developed and commercialized several biopharmaceuticals including recombinant human growth hormone ("Genheal") approved in China since at least the late '90s for growth disorders. The company also markets an oral recombinant B-subunit/whole cell cholera vaccine ("OraVacs"), and is advancing biosimilars and other biologics through clinical development. Their pipeline includes assets in endocrinology/metabolic disease, infectious disease, and ophthalmology.

Therapeutic areas: EndocrinologyOphthalmologyInfectious Diseases
Modalities: Recombinant proteins/peptides (e.g., recombinant human growth hormone, parathyroid hormone)Biosimilars (e.g., ranibizumab biosimilar)Prophylactic vaccines (e.g., oral cholera vaccine)
Industry: Biotech

Drug pipeline

5 assets

recombinant B subunit/whole-cell cholera vaccine

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Shanghai United Cell Biotechnology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai United Cell Biotechnology Co., Ltd..

Explore the full profile